BUY!
Target Order: 148.48 EUR
Stop Order: 120.03 EUR
1.) GoodNEWS for Moderna: The British government wants to continue its course in the fight against the coronavirus. The first deliveries from the pharmaceutical company Moderna are expected in April, told member Oliver Dowden today. It would be the third vaccine to be used in the UK. To date, more than 30 million adults - 57% - have received a first dose.
2.) M30 chart shows a support level at the current price range. A rejection is expected.
3.) Execute the trade based on the recommended TP and SL levels!
4.) SL below last significant low!
Target Order: 148.48 EUR
Stop Order: 120.03 EUR
1.) GoodNEWS for Moderna: The British government wants to continue its course in the fight against the coronavirus. The first deliveries from the pharmaceutical company Moderna are expected in April, told member Oliver Dowden today. It would be the third vaccine to be used in the UK. To date, more than 30 million adults - 57% - have received a first dose.
2.) M30 chart shows a support level at the current price range. A rejection is expected.
3.) Execute the trade based on the recommended TP and SL levels!
4.) SL below last significant low!
トレード終了: ストップロスに到達
SL was too optimistic
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。